
Reset all filters
01 1Gowling Lafleur Henderson LLP
02 2McCarthy Tétrault
Reset all filters
01 12110518
02 22634547
Reset all filters
01 3ABATACEPT
Reset all filters
01 2SOLUTION
02 1Sterile Powder for Injection
Reset all filters
01 12012-06-16
02 22026-12-19
Patent Expiration Date : 2026-12-19
Date Granted : 2016-10-11
Brand Name : ORENCIA
Patent Number : 2634547
Filing Date : 2006-12-19
Strength per Unit : 125 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-19
Date Granted : 2016-10-11
Patent Expiration Date : 2012-06-16
Date Granted : 2007-05-22
Brand Name : ORENCIA
Patent Number : 2110518
Filing Date : 1992-06-16
Strength per Unit : 250mg / vial
Dosage Form : Sterile Powder for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2012-06-16
Date Granted : 2007-05-22
Patent Expiration Date : 2026-12-19
Date Granted : 2016-10-11
Brand Name : ORENCIA
Patent Number : 2634547
Filing Date : 2006-12-19
Strength per Unit : 125 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-19
Date Granted : 2016-10-11
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF